Antimicrobial prescriptions for older patients in dental medicine: A four-year retrospective study in Japan.

IF 1.9 4区 医学 Q3 INFECTIOUS DISEASES Journal of Infection and Chemotherapy Pub Date : 2025-02-28 DOI:10.1016/j.jiac.2025.102675
Akira Kurishima, Yasuhiro Sasaki, Yusuke Kuwai, Mari Irie, Satoshi Miyata, Yoshiharu Fukuda
{"title":"Antimicrobial prescriptions for older patients in dental medicine: A four-year retrospective study in Japan.","authors":"Akira Kurishima, Yasuhiro Sasaki, Yusuke Kuwai, Mari Irie, Satoshi Miyata, Yoshiharu Fukuda","doi":"10.1016/j.jiac.2025.102675","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Antimicrobial use (AMU) in Japan is characterized by a high prevalence of oral third-generation cephalosporin prescriptions, especially in dental medicine. However, few studies have examined the time trends and factors influencing AMU in older individuals seeking dental care. Therefore, in this study, we aimed to investigate AMU, particularly third-generation cephalosporin, in a cohort of older adults.</p><p><strong>Methods: </strong>This retrospective study analyzed the dental prescription health insurance claims data of patients aged ≥ 75 years in one metropolitan area from 2018 to 2021. The antimicrobials were categorized, and the number of defined daily doses (DDDs) per 1,000 inhabitants per day (DID) was calculated to assess trends over this period. Multivariate logistic regression analysis was performed to identify factors associated with third-generation cephalosporin prescriptions.</p><p><strong>Results: </strong>This database contains 58,655 patients, of whom 15,038 were prescribed antimicrobials from dentistry. Our findings suggest that third-generation cephalosporins accounted for 44.8% of all antimicrobial prescriptions, with a noticeable decreasing trend in DID over the study period. Factors significantly associated with third-generation cephalosporin prescriptions included dental association membership (adjusted odds ratio [AOR] 0.72, 95% confidence interval [CI] 0.63-0.82), fiscal year (AOR 0.86, 95% CI 0.83-0.89), and their interaction.</p><p><strong>Conclusions: </strong>The findings suggest that the pattern of prescribing third-generation cephalosporins in dental medicine might be shifting owing to heightened awareness of antimicrobial resistance (AMR) and educational initiatives by groups, such as dental associations. Effective educational and policy interventions by professional associations could reduce inappropriate antimicrobial prescriptions, thereby mitigating AMR on a large scale.</p>","PeriodicalId":16103,"journal":{"name":"Journal of Infection and Chemotherapy","volume":" ","pages":"102675"},"PeriodicalIF":1.9000,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Infection and Chemotherapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jiac.2025.102675","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Antimicrobial use (AMU) in Japan is characterized by a high prevalence of oral third-generation cephalosporin prescriptions, especially in dental medicine. However, few studies have examined the time trends and factors influencing AMU in older individuals seeking dental care. Therefore, in this study, we aimed to investigate AMU, particularly third-generation cephalosporin, in a cohort of older adults.

Methods: This retrospective study analyzed the dental prescription health insurance claims data of patients aged ≥ 75 years in one metropolitan area from 2018 to 2021. The antimicrobials were categorized, and the number of defined daily doses (DDDs) per 1,000 inhabitants per day (DID) was calculated to assess trends over this period. Multivariate logistic regression analysis was performed to identify factors associated with third-generation cephalosporin prescriptions.

Results: This database contains 58,655 patients, of whom 15,038 were prescribed antimicrobials from dentistry. Our findings suggest that third-generation cephalosporins accounted for 44.8% of all antimicrobial prescriptions, with a noticeable decreasing trend in DID over the study period. Factors significantly associated with third-generation cephalosporin prescriptions included dental association membership (adjusted odds ratio [AOR] 0.72, 95% confidence interval [CI] 0.63-0.82), fiscal year (AOR 0.86, 95% CI 0.83-0.89), and their interaction.

Conclusions: The findings suggest that the pattern of prescribing third-generation cephalosporins in dental medicine might be shifting owing to heightened awareness of antimicrobial resistance (AMR) and educational initiatives by groups, such as dental associations. Effective educational and policy interventions by professional associations could reduce inappropriate antimicrobial prescriptions, thereby mitigating AMR on a large scale.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
针对牙科老年患者的抗菌药物处方:日本一项为期四年的回顾性研究。
背景:日本抗菌药物使用(AMU)的特点是口服第三代头孢菌素处方的高流行率,尤其是在牙科医疗中。然而,很少有研究对牙科就诊的老年人使用抗菌药物的时间趋势和影响因素进行研究。因此,在本研究中,我们旨在调查一组老年人的 AMU,尤其是第三代头孢菌素:这项回顾性研究分析了 2018 年至 2021 年一个大都市地区年龄≥75 岁患者的牙科处方医疗保险理赔数据。对抗菌药物进行了分类,并计算了每千名居民每天的定义日剂量(DDD)数,以评估这一时期的趋势。进行了多变量逻辑回归分析,以确定与第三代头孢菌素处方相关的因素:该数据库包含 58,655 名患者,其中 15,038 名患者的抗菌药处方来自牙科。我们的研究结果表明,第三代头孢菌素占所有抗菌药物处方的 44.8%,在研究期间,DID 呈明显下降趋势。与第三代头孢菌素处方明显相关的因素包括牙科协会会员资格(调整赔率[AOR]0.72,95%置信区间[CI]0.63-0.82)、财政年度(AOR 0.86,95%置信区间[CI]0.83-0.89)及其交互作用:研究结果表明,由于对抗菌素耐药性(AMR)认识的提高以及牙科协会等团体开展的教育活动,牙科医学中第三代头孢菌素的处方模式可能正在发生变化。专业协会采取有效的教育和政策干预措施可以减少不适当的抗菌药物处方,从而大规模缓解抗菌药物耐药性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Infection and Chemotherapy
Journal of Infection and Chemotherapy INFECTIOUS DISEASES-PHARMACOLOGY & PHARMACY
CiteScore
4.10
自引率
4.50%
发文量
303
审稿时长
47 days
期刊介绍: The Journal of Infection and Chemotherapy (JIC) — official journal of the Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases — welcomes original papers, laboratory or clinical, as well as case reports, notes, committee reports, surveillance and guidelines from all parts of the world on all aspects of chemotherapy, covering the pathogenesis, diagnosis, treatment, and control of infection, including treatment with anticancer drugs. Experimental studies on animal models and pharmacokinetics, and reports on epidemiology and clinical trials are particularly welcome.
期刊最新文献
Current status and challenges of health economic evaluations related to antimicrobial stewardship in Japan: A scoping review up to 2023 A case of meningitis treated with intraventricular vancomycin in an infant Antimicrobial prescriptions for older patients in dental medicine: A four-year retrospective study in Japan. Endoscopic findings among healthy adults with asymptomatic norovirus infection in Japan: A single-center cross-sectional study A case of post-outbreak acute hepatitis a in a Japanese man who have sex with men infected with RIVM-HAV16-090 strain
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1